The system offers zero-exchange delivery with a unique atraumatic design to reduce steps and eliminate rewiring during access ...
Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has received 510 (k) clearance from ...
Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.
US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried out using its device ...
BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...
BALTIMORE, October 24, 2025--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today ...
Transseptal Solutions, developer of a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation to treat multiple clinical indications, has received its first ...
Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation to introduce various cardiovascular catheters ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
CLEVELAND, March 1, 2011 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation technology, is happy to announce the release of their new ...
Physicians with limited experience closing the left atrial appendage (LAA) with the Watchman device (Boston Scientific) in patients with atrial fibrillation do not appear to have worse clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results